Affimed N.V. EV 2011-2026 | AFMD

EV Jährlich Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
478 M	325 M	151 M	183 M	30.9 M	36 M	45.7 M	147 M	106 M	80.3 M	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
478 M	30.9 M	158 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Graybug Vision GRAY	8.71 M	-	-11.23 %	$ 9.65 M	USA
AbCellera Biologics ABCL	1.22 B	$ 3.64	-1.89 %	$ 1.09 B	Canada
ADMA Biologics ADMA	3.84 B	$ 16.45	0.43 %	$ 3.92 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
ANI Pharmaceuticals ANIP	1.91 B	$ 76.75	0.85 %	$ 1.48 B	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 19.93	-1.14 %	$ 2.51 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Aptorum Group Limited APM	9.45 M	$ 0.83	4.23 %	$ 4.53 M	China
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Brainstorm Cell Therapeutics BCLI	15.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	3.22 B	$ 8.4	-1.81 %	$ 1.39 B	Britain
Axsome Therapeutics AXSM	8.95 B	$ 163.82	-0.14 %	$ 8.15 B	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
BridgeBio Pharma BBIO	15.5 B	$ 66.98	3.8 %	$ 12.8 B	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
BioLineRx Ltd. BLRX	15 M	$ 2.88	2.51 %	$ 908 M	Israel
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
BioMarin Pharmaceutical BMRN	11.9 B	$ 60.75	3.79 %	$ 11.7 B	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
CohBar CWBR	410 K	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	112 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Cabaletta Bio CABA	-155 M	$ 3.41	4.77 %	$ 3.98 M	USA
Capricor Therapeutics CAPR	177 M	$ 25.71	-0.5 %	$ 688 M	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Codexis CDXS	354 M	$ 1.1	12.24 %	$ 80.7 M	USA
Certara CERT	1.38 B	$ 7.33	1.24 %	$ 1.18 B	USA
Entasis Therapeutics Holdings ETTX	51.1 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	75.8 M	-	7.55 %	$ 38.1 M	USA